Award

Delivery Order #SPE2D226F1364

Delivery Order for Moxifloxacin Hydrocortisone under Pharmaceutical IDV

Buyer

Defense Logistics Agency

Award Amount

$17.91

Ceiling

$17.91

Awarded

February 26, 2026

Period of Performance

Feb 26, 2026 – Feb 26, 2026

Identifier

SPE2D226F1364

NAICS

325411

This award is a delivery order contract, issued under a larger indefinite delivery contract (IDV) for pharmaceutical supplies. The recipient is DMS Pharmaceutical Group Inc., a well-established pharmaceutical manufacturer and distributor specializing in providing essential medications to government agencies. The specific product procured under this delivery order is moxifloxacin hydrocortisone, a critical pharmaceutical agent likely used to treat infections and inflammation. This award is significant as it supports the government's ongoing effort to maintain an uninterrupted supply of vital medications, thereby strengthening public health systems. The scope encompasses the delivery of this specific drug to the designated location in Park Ridge, Illinois, reflecting a targeted and timely fulfillment of a pharmaceutical need. The larger IDV contract, awarded competitively, ensures sustained and reliable pharmaceutical provision over multiple years. This delivery order represents a multi-year agreement fulfilled within a short timeframe, supporting urgent or scheduled healthcare demands.

Description

8511947075!MOXIFLOXACIN HYDROC

View original record